Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 553-563

  Ventetuolo, Corey E ^a,i   Mitra, Nandita ^b   Wan, Fei ^b   Manichaikul, Ani ^c   Barr, R Graham ^d   Johnson, Craig ^e   Bluemke, David A ^f   Lima, Joao A C ^g   Tandri, Hari ^g   Ouyang, Pamela ^g   Kawut, Steven M ^b,h  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRONE; ANDROGEN RECEPTOR; CYTOCHROME P450 1B1; ESTRADIOL; TESTOSTERONE; AR PROTEIN, HUMAN; CYP1B1 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CARCINOGENESIS; CARDIOVASCULAR PARAMETERS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEART FUNCTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC MASS; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICULAR FUNCTION; HETEROZYGOTE; HORMONE METABOLISM; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; GENETICS; HAPLOTYPE; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1B1; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, ANDROGEN; SEX FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84958078249     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01083-2015     Document Type: Article

References (48)

1. Lahm T, Tuder RM, Petrache I. Progress in solving the sex hormone paradox in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 307: L7-L26.
2. Kawut SM, Krowka MJ, Trotter JF, et al. Clinical risk factors for portopulmonary hypertension. Hepatology 2008; 48: 196-203.
3. Roberts KE, Fallon MB, Krowka MJ, et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med 2009; 179: 835-842.
4. Austin E, Cogan J, West J, et al. Alterations in estrogen metabolism: Implications for higher penetrance of FPAH in females. Eur Respir J 2009; 34: 1093-1099.
5. Mair KM, Wright AF, Duggan N, et al. Sex-dependent influence of endogenous estrogen in pulmonary hypertension. Am J Respir Crit Care Med 2014; 190: 456-467.
6. White K, Johansen AK, Nilsen M, et al. Activity of the estrogen-metabolizing enzyme cytochrome p450 1b1 influences the development of pulmonary arterial hypertension. Circulation 2012; 126: 1087-1098.
7. Meyer P, Filippatos GS, Ahmed MI, et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010; 121: 252-258.
8. Mohammed SF, Hussain I, Abou Ezzeddine OF, et al. Right ventricular function in heart failure with preserved ejection fraction: A community-based study. Circulation 2014; 130: 2310-2320.
9. Morrison DA, Adcock K, Collins CM, et al. Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987; 9: 1219-1229.
10. Thum T, Borlak J. Testosterone, cytochrome p450, and cardiac hypertrophy. FASEB J 2002; 16: 1537-1549.
11. Thum T, Borlak J. Gene expression in distinct regions of the heart. Lancet 2000; 355: 979-983.
12. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
13. Melenovsky V, Hwang SJ, Lin G, et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35: 3452-3462.
14. Ventetuolo CE, Ouyang P, Bluemke DA, et al. Sex hormones are associated with right ventricular structure and function: The MESA-Right Ventricle study. Am J Respir Crit Care Med 2011; 183: 659-667.
15. Ventetuolo CE, Praestgaard A, Palevsky HI, et al. Sex and haemodynamics in pulmonary arterial hypertension. Eur Respir J 2014; 43: 523-530.
16. Gabler NB, French B, Strom BL, et al. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest 2012; 141: 20-26.
17. Jacobs W, van de Veerdonk MC, Trip P, et al. The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. Chest 2014; 145: 1230-1236.
18. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
19. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: Baseline characteristics from the REVEAL registry. Chest 2010; 137: 376-387.
20. Davis KK, Lilienfeld DE, Doyle RL. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. J Natl Med Assoc 2008; 100: 69-72.
21. Hyduk A, Croft JB, Ayala C, et al. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ 2005; 54: 1-28.
22. Kawut SM, Lima JAC, Barr RG, et al. Sex and race differences in right ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study. Circulation 2011; 123: 2542-2551.
23. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 2002; 156: 871-881.
24. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008; 3: e3583.
25. Golden SH, Dobs AS, Vaidya D, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007; 92: 1289-1295.
26. Psaty B, Lee M, Savage PJ, et al. Assessing the use of medication in the elderly: Methods and initial experience in the Cardiovascular Health Study: The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 1992; 45: 683-692.
27. Greenland S, Brumback B. An overview of relations among causal modelling methods. Int J Epidemiol 2002; 31: 1030-1037.
28. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340-349.
29. Diergaarde B, Potter JD, Jupe ER, et al. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 1751-1759.
30. Kato I, Cichon M, Yee CL, et al. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Cancer Epidemiol 2009; 33: 24-30.
31. Wenzlaff AS, Cote ML, Bock CH, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: A population-based study. Carcinogenesis 2005; 26: 2207-2212.
32. Paracchini V, Raimondi S, Gram IT, et al. Meta- and pooled analyses of the cytochrome p-450 1B1 Val432Leu polymorphism and breast cancer: A HuGE-GSEC review. Am J Epidemiol 2007; 165: 115-125.
33. Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT, et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 2004; 125: 572-579.
34. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58: 2511-2519.
35. Bradlow WM, Hughes ML, Keenan NG, et al. Measuring the heart in pulmonary arterial hypertension (PAH): Implications for trial study size. J Magn Reson Imaging 2010; 31: 117-124.
36. Heckbert SR, Post W, Pearson GDN, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: The Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2006; 48: 2285-2292.
37. Ouyang P, Vaidya D, Dobs A, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009; 204: 255-261.
38. Dubey RK, Jackson EK, Gillespie DG, et al. Cytochromes 1a1/1b1- and catechol-o-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab 2005; 90: 247-255.
39. Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 1991; 16: 59-66.
40. Kanasaki K, Palmsten K, Sugimoto H, et al. Deficiency in catechol-o-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008; 453: 1117-1121.
41. Bremner WJ. Testosterone deficiency and replacement in older men. N Engl J Med 2010; 363: 189-191.
42. Marsh JD, Lehmann MH, Ritchie RH, et al. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998; 98: 256-261.
43. Hemnes AR, Maynard KB, Champion HC, et al. Testosterone negatively regulates right ventricular load stress responses in mice. Pulm Circ 2012; 2: 352-358.
44. He J, Peng R, Yuan Z, et al. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: A retrospective analysis based on a tissue microarray. Med Oncol 2012; 29: 406-410.
45. Tang D, Xu S, Zhang Q, et al. The expression and clinical significance of the androgen receptor and e-cadherin in triple-negative breast cancer. Med Oncol 2012; 29: 526-533.
46. Wellejus A, Olsen A, Tjonneland A, et al. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: A prospective study. Cancer Epidemiol Biomarkers Prev 2005; 14: 2137-2142.
47. Falk RT, Rossi SC, Fears TR, et al. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16α ±-hydroxyestrone, and their ratio: Reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol Biomarkers Prev 2000; 9: 81-87.
48. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007; 447: 655-660.